SCHEMBL4382145

SCHEMBL4382145

O=C1CC=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2115260 0.71
SCHEMBL3630410 0.67
SCHEMBL7277052 0.67
SCHEMBL3621983 0.60
SCHEMBL1199564 0.58
SCHEMBL616020 0.58
SCHEMBL1160929 0.57
SCHEMBL622463 0.57
SCHEMBL11509290 0.57
SCHEMBL11490587 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 WO disclosed
EP-4562002-A1 SUBSTITUTED BICYCLIC HETEROARYL SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER Nodus Oncology Limited (GB) 2025-06-04 EP disclosed
WO-2024023330-A1 SUBSTITUTED BICYCLIC HETEROARYL SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER NODUS ONCOLOGY LIMITED (GB) 2024-02-01 WO disclosed
CN-112638917-B Heterocyclic compounds as kinase inhibitors, compositions comprising the same, and methods of use thereof 捷思英达控股有限公司 2023-09-08 CN disclosed
CN-116096710-A 4-oxo-3, 4-dihydroquinazolinone compounds for the treatment of BRAF related diseases and disorders 阿雷生物药品公司 2023-05-09 CN disclosed
CN-109071467-A Acyclic antiviral agent 艾丽奥斯生物制药有限公司 2018-12-21 CN disclosed
CN-105189520-B Carbostyril derivative 埃科特莱茵药品有限公司 2017-10-10 CN disclosed
CN-104640862-B Novel heteroaryl and heterocycle compounds, composition and methods thereof 和记黄埔医药(上海)有限公司 2017-02-15 CN disclosed
WO-2016188506-A1 SOLID FORMS OF 5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]QUINAZOLIN-4-ONE AND PREPARATION THEREOF ZENTIVA, K.S. (CZ) 2016-12-01 WO disclosed
CN-103649089-B Pyrrolotriazinones as PI3K inhibitors 阿尔米雷尔有限公司 2016-06-29 CN disclosed
EP-1278748-A2 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2003-01-29 EP disclosed
US-20030008251-A1 Photothermographic material FUJIFILM CORPORATION (JP) 2003-01-09 US disclosed
US-20020164552-A1 Thermally processed image recording material FUJIFILM CORPORATION (JP) 2002-11-07 US disclosed
US-20020155401-A1 Photothermographic material FUJIFILM CORPORATION (JP) 2002-10-24 US disclosed
US-6395466-B1 MIXTURE OF ORGANIC SILVER SALT, REDUCING AGENTS, PHOTOSENSITIVE SILVER HALIDE GRAINS AND BINDER FUJI PHOTO FILM CO., LTD. (JP) 2002-05-28 US disclosed
US-20020055068-A1 Photothermographic material FUJIFILM CORPORATION (JP) 2002-05-09 US disclosed
US-6329127-B1 HALOGEN-RELEASING PRECURSOR HAVING AT LEAST ONE DISSOCIATIVE OR HYDROPHILIC SUBSTITUENT AND A SECOND HYDROPHOBIC HALOGEN-RELEASING PRECURSOR; FUJI PHOTO FILM CO., LTD. (JP) 2001-12-11 US disclosed
WO-2001081346-A2 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2001-11-01 WO disclosed
US-6303615-B1 FOR THERAPY AND PROPHYLAXIS OF NEURODEGENERATIVE DISORDERS, CENTRAL NERVOUS SYSTEM DISORDERS, CONVULSIONS PFIZER INC 2001-10-16 US disclosed
EP-1041433-A1 Heat-developable photosensitive material and method for forming image using the same FUJI PHOTO FILM CO., LTD. (JP) 2000-10-04 EP disclosed